• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

根除幽门螺杆菌预防胃癌:批判性评价。

The eradication of Helicobacter pylori to prevent gastric cancer: a critical appraisal.

机构信息

a Department of Internal Medicine, Kaohsiung Municipal Hsiao-Kang Hospital , Kaohsiung Medical University , Kaohsiung , Taiwan.

b Department of Internal Medicine, Kaohsiung Medical University Hospital , Kaohsiung Medical University , Kaohsiung , Taiwan.

出版信息

Expert Rev Gastroenterol Hepatol. 2019 Jan;13(1):17-24. doi: 10.1080/17474124.2019.1542299. Epub 2018 Nov 13.

DOI:10.1080/17474124.2019.1542299
PMID:30791844
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6391731/
Abstract

Gastric cancer is one of the top causes of cancer-related death worldwide. How to eliminate gastric cancer is an urgent public-health issue. Areas covered: In this review, we present up-to-date results of studies on gastric cancer prevention through the eradication of Helicobacter pylori and discuss strategies and obstacles for the implementation of population-wide screening and treatment of this pathogen to prevent gastric cancer. Expert commentary: Gastric cancer is an inflammation-associated cancer with multistep carcinogenesis. The process consists of H. pylori infection, ongoing inflammation, development of metaplastic epithelia and genetic instability eventuating in gastric cancer. H. pylori infection is critical for development of the disease and studies have consistently shown that H. pylori eradication results in a reduction in (a) gastric mucosal inflammation, (b) progression of histologic damage, (c) risk of peptic ulcers and ulcer recurrence, and (d) risk of gastric cancer. Compared with a large number of clinical trials evaluating chemopreventive approaches, studies of population-wide screening, and eradication of H. pylori have only recently begun and only in high-risk populations. To eliminate gastric cancer requires information on how to implement an effective program for screening and treatment of H. pylori taking into consideration the other health priorities in any specific population.

摘要

胃癌是全球癌症相关死亡的主要原因之一。如何消除胃癌是一个紧迫的公共卫生问题。

涵盖领域

在这篇综述中,我们介绍了通过根除幽门螺杆菌预防胃癌的最新研究结果,并讨论了实施针对这种病原体的人群筛查和治疗策略及障碍,以预防胃癌。

专家评论

胃癌是一种与炎症相关的癌症,具有多步骤的癌变过程。该过程包括幽门螺杆菌感染、持续的炎症、上皮化生的发展以及导致胃癌的遗传不稳定性。幽门螺杆菌感染对疾病的发展至关重要,研究一致表明,根除幽门螺杆菌可降低(a)胃黏膜炎症、(b)组织学损伤进展、(c)消化性溃疡和溃疡复发风险,以及(d)胃癌风险。与大量评估化学预防方法的临床试验相比,人群筛查和幽门螺杆菌根除的研究最近才开始,并且仅在高危人群中进行。要消除胃癌,需要考虑到任何特定人群中的其他健康优先事项,了解如何实施针对幽门螺杆菌的有效筛查和治疗计划。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4f67/6391731/b5b78298ccf2/nihms-1511949-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4f67/6391731/6e5701a402fa/nihms-1511949-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4f67/6391731/798a1a61f808/nihms-1511949-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4f67/6391731/b5b78298ccf2/nihms-1511949-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4f67/6391731/6e5701a402fa/nihms-1511949-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4f67/6391731/798a1a61f808/nihms-1511949-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4f67/6391731/b5b78298ccf2/nihms-1511949-f0004.jpg

相似文献

1
The eradication of Helicobacter pylori to prevent gastric cancer: a critical appraisal.根除幽门螺杆菌预防胃癌:批判性评价。
Expert Rev Gastroenterol Hepatol. 2019 Jan;13(1):17-24. doi: 10.1080/17474124.2019.1542299. Epub 2018 Nov 13.
2
Metachronous gastric cancer after successful Helicobacter pylori eradication.幽门螺杆菌成功根除后发生的异时性胃癌。
World J Gastroenterol. 2014 Sep 7;20(33):11552-9. doi: 10.3748/wjg.v20.i33.11552.
3
Helicobacter pylori associated chronic gastritis, clinical syndromes, precancerous lesions, and pathogenesis of gastric cancer development.幽门螺杆菌相关的慢性胃炎、临床综合征、癌前病变及胃癌发生的发病机制。
World J Gastroenterol. 2014 May 14;20(18):5461-73. doi: 10.3748/wjg.v20.i18.5461.
4
Association Between Helicobacter pylori Eradication and Gastric Cancer Incidence: A Systematic Review and Meta-analysis.幽门螺杆菌根除与胃癌发病率的关系:系统评价和荟萃分析。
Gastroenterology. 2016 May;150(5):1113-1124.e5. doi: 10.1053/j.gastro.2016.01.028. Epub 2016 Feb 2.
5
Roadmap for elimination of gastric cancer in Korea.韩国胃癌消除路线图。
Korean J Intern Med. 2015 Mar;30(2):133-9. doi: 10.3904/kjim.2015.30.2.133. Epub 2015 Feb 27.
6
Chemoprevention of gastric cancer by Helicobacter pylori eradication and its underlying mechanism.通过根除幽门螺杆菌预防胃癌及其潜在机制。
J Gastroenterol Hepatol. 2019 Aug;34(8):1287-1295. doi: 10.1111/jgh.14646. Epub 2019 Mar 27.
7
Chemoprevention of gastric cancer development after eradication therapy in an East Asian population: Meta-analysis.东亚人群根除治疗后胃癌发展的化学预防:荟萃分析。
World J Gastroenterol. 2020 Apr 21;26(15):1820-1840. doi: 10.3748/wjg.v26.i15.1820.
8
Screening and eradication of for gastric cancer prevention: the Taipei global consensus.胃癌预防的筛查和根除:台北全球共识。
Gut. 2020 Dec;69(12):2093-2112. doi: 10.1136/gutjnl-2020-322368. Epub 2020 Oct 1.
9
Strategies for Prevention of Gastric Cancer: Progress from Mass Eradication Trials.胃癌预防策略:大规模根除试验的进展
Dig Dis. 2016;34(5):500-4. doi: 10.1159/000445229. Epub 2016 Jun 22.
10
Treatment of Helicobacter pylori and prevention of gastric cancer.幽门螺杆菌的治疗与胃癌的预防
J Dig Dis. 2008 Feb;9(1):8-13. doi: 10.1111/j.1443-9573.2007.00315.x.

引用本文的文献

1
Effectiveness of first line therapy for Helicobacter pylori infection in children and adolescents: A multicenter study in the United Arab Emirates.儿童和青少年幽门螺杆菌感染一线治疗的有效性:阿拉伯联合酋长国的一项多中心研究。
PLoS One. 2025 Aug 28;20(8):e0318315. doi: 10.1371/journal.pone.0318315. eCollection 2025.
2
Precancerous pathways to gastric cancer: a review of experimental animal models recapitulating the correa cascade.胃癌的癌前病变途径:对重现科雷亚级联反应的实验动物模型的综述
Front Cell Dev Biol. 2025 Jul 2;13:1620756. doi: 10.3389/fcell.2025.1620756. eCollection 2025.
3
Proton pump inhibitors and the risk of gastric cancer: a systematic review, evidence synthesis and life course epidemiology perspective.

本文引用的文献

1
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.全球癌症统计数据 2018:GLOBOCAN 对全球 185 个国家/地区 36 种癌症的发病率和死亡率的估计。
CA Cancer J Clin. 2018 Nov;68(6):394-424. doi: 10.3322/caac.21492. Epub 2018 Sep 12.
2
Effects of screening and universal healthcare on long-term colorectal cancer mortality.筛查和全民医保对长期结直肠癌死亡率的影响。
Int J Epidemiol. 2019 Apr 1;48(2):538-548. doi: 10.1093/ije/dyy182.
3
Efficacy, immunogenicity, and safety of a parenteral vaccine against Helicobacter pylori in healthy volunteers challenged with a Cag-positive strain: a randomised, placebo-controlled phase 1/2 study.
质子泵抑制剂与胃癌风险:一项系统综述、证据综合及生命历程流行病学视角分析
BMJ Open Gastroenterol. 2025 Apr 19;12(1):e001719. doi: 10.1136/bmjgast-2024-001719.
4
Exploration of the optimal regimen of gastric mucosal cleansing medication for the population before ME-NBI screening: study protocol for a single-center, single-blind, randomized controlled trial.ME-NBI筛查前人群胃黏膜清洁用药最佳方案的探索:一项单中心、单盲、随机对照试验的研究方案
Front Med (Lausanne). 2025 Apr 2;12:1516271. doi: 10.3389/fmed.2025.1516271. eCollection 2025.
5
Analysis of garlic intake on atrophic gastritis risk in different infectious states of Helicobacter pylori in a case-control study.一项病例对照研究中大蒜摄入量对幽门螺杆菌不同感染状态下萎缩性胃炎风险的分析。
Sci Rep. 2025 Mar 12;15(1):8481. doi: 10.1038/s41598-025-92376-z.
6
Multidisciplinary Approach Improves Eradication Rate and Safety in Refractory Helicobacter pylori Infection.多学科方法提高难治性幽门螺杆菌感染的根除率及安全性
Clin Transl Gastroenterol. 2025 Feb 1;16(2):e00804. doi: 10.14309/ctg.0000000000000804.
7
Insights into macrolide resistance: a comprehensive systematic review and meta-analysis.大环内酯类耐药性研究进展:一项全面的系统评价与荟萃分析
Front Microbiol. 2024 Oct 30;15:1481763. doi: 10.3389/fmicb.2024.1481763. eCollection 2024.
8
Identification of novel drug targets for : structure-based virtual screening of potential inhibitors against DAH7PS protein involved in the shikimate pathway.莽草酸途径中参与DAH7PS蛋白的潜在抑制剂的基于结构的虚拟筛选:新型药物靶点的鉴定
Front Bioinform. 2024 Oct 18;4:1482338. doi: 10.3389/fbinf.2024.1482338. eCollection 2024.
9
Access to radiotherapy in improving gastric cancer care quality and equality.获得放射治疗对提高胃癌护理质量和平等性的作用。
Commun Med (Lond). 2024 Nov 2;4(1):225. doi: 10.1038/s43856-024-00655-z.
10
Clinicopathologic Features of Early Gastric Cancer after Eradication in Japanese Patients: Comparative Study between Early (<10 Years) and Late (>10 Years) Onset.日本患者根除治疗后早期胃癌的临床病理特征:早期(<10年)与晚期(>10年)发病的比较研究
Cancers (Basel). 2024 Sep 14;16(18):3154. doi: 10.3390/cancers16183154.
在健康志愿者中用一种含 CagA 阳性菌株的疫苗进行的 1/2 期随机、安慰剂对照的Ⅰ期研究:一种针对幽门螺杆菌的注射用疫苗的有效性、免疫原性和安全性。
Lancet Gastroenterol Hepatol. 2018 Oct;3(10):698-707. doi: 10.1016/S2468-1253(18)30125-0. Epub 2018 Jul 2.
4
Cost Effectiveness of Gastric Cancer Screening According to Race and Ethnicity.基于种族和民族的胃癌筛查的成本效益。
Gastroenterology. 2018 Sep;155(3):648-660. doi: 10.1053/j.gastro.2018.05.026. Epub 2018 May 17.
5
Helicobacter pylori Therapy for the Prevention of Metachronous Gastric Cancer.幽门螺杆菌治疗预防胃肿瘤。
N Engl J Med. 2018 Mar 22;378(12):1085-1095. doi: 10.1056/NEJMoa1708423.
6
Houston Consensus Conference on Testing for Helicobacter pylori Infection in the United States.美国休斯顿幽门螺杆菌感染检测共识会议
Clin Gastroenterol Hepatol. 2018 Jul;16(7):992-1002.e6. doi: 10.1016/j.cgh.2018.03.013. Epub 2018 Mar 17.
7
Editorial: Helicobacter pylori and gastric cancer in Alaskan Natives: Time to stop studying H. pylori and to eradicate it.社论:阿拉斯加原住民中的幽门螺杆菌与胃癌:是时候停止对幽门螺杆菌的研究并根除它了。
Helicobacter. 2018 Jun;23(3):e12478. doi: 10.1111/hel.12478. Epub 2018 Mar 2.
8
Serum Pepsinogen as a Predictor for Gastric Cancer Death: A 16-Year Community-based Cohort Study.血清胃蛋白酶原作为胃癌死亡的预测因子:一项长达 16 年的社区为基础的队列研究。
J Clin Gastroenterol. 2019 May/Jun;53(5):e186-e193. doi: 10.1097/MCG.0000000000000992.
9
Helicobacter pylori eradication may influence timing of endoscopic surveillance for gastric cancer in patients with gastric precancerous lesions: A retrospective study.幽门螺杆菌根除可能影响胃癌前病变患者的胃癌内镜监测时机:一项回顾性研究。
Medicine (Baltimore). 2018 Jan;97(4):e9734. doi: 10.1097/MD.0000000000009734.
10
Gastritis staging in the endoscopic follow-up for the secondary prevention of gastric cancer: a 5-year prospective study of 1755 patients.内镜随访中胃癌二级预防的胃炎分期:1755 例患者的 5 年前瞻性研究。
Gut. 2019 Jan;68(1):11-17. doi: 10.1136/gutjnl-2017-314600. Epub 2018 Jan 6.